0001144204-17-047477.txt : 20170911 0001144204-17-047477.hdr.sgml : 20170911 20170911163425 ACCESSION NUMBER: 0001144204-17-047477 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170313 FILED AS OF DATE: 20170911 DATE AS OF CHANGE: 20170911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 171079304 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 3 1 v473695_form3.xml FORM 3 X0206 3 2017-03-13 0 0001644963 AVENUE THERAPEUTICS, INC. ATXI 0001055666 KRANZLER JAY D C/O AVENUE THERAPEUTICS, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 Common Stock (Restricted) 50000 D The 50,000 shares of restricted Common Stock will vest as follows: One-third on August 8, 2020, one-third on August 8, 2021 and one-third on August 8, 2022. /s/ Lucy Lu, M.D., Attorney-in-Fact 2017-09-11